UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

"We're also providing a scalable blueprint to expand agentic automation across the enterprise, transforming how business users engage with ERP through seamless collaboration betwe ...

UiPath (NYSE:PATH) executives used the company’s latest earnings call question-and-answer session to emphasize what they ...

Will collaborate with other member organizations to develop and expand open protocols, tooling, and best practices for agent-based AI systems NEW YORK--(BUSINESS WIRE)-- UiPath (PATH) (NYSE: PATH), a ...

UiPath (NYSE: PATH), a global leader in agentic automation, today announced its UiPath Screen Agent powered by Claude Opus 4.5 achieved a No. 1 ranking on the OSWorld-Verified benchmark, an ...

A detailed overview of the challenges of benefit claims processing in the public sector, and the benefits of applying agentic automation. It highlights issues like complex eligibility criteria and ...

UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has been named a Leader in The Forrester Wave(TM): Autonomous Testing Platforms, Q4 2025, reinforcing the company's ...

After falling by over 80% from its previous peak, UiPath (NYSE: PATH) stock trades at a more favorable valuation that makes it a compelling buy for investors. The agentic AI specialist still trades at ...

Artificial intelligence (AI) is changing the world we live in, and the next big change is coming in the form of AI agents.

UiPath closes fiscal year 2026 on a high, with co-Founder and CEO Daniel Dines making a bold case that falling AI development costs are good for the automation market, not a threat to it.